NL-OMON54499已完成3 期
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial. - BOOG 2013-08
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 1,730 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,730
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Aged 18 years or older
- •- Pathologically confirmed invasive unilateral breast carcinoma
- •- A clinical T1-2 tumour (<= 5cm)
- •- Will be treated with lumpectomy followed by whole breast radiotherapy
- •- Clinically node negative status: no signs of axillary lymph node metastases
- •at physical examination and preoperative axillary ultrasound (or negative
- •cyto-/histopathology)
- •- Written informed consent
排除标准
- •- Clinically node positive pre-operative
- •- Bilateral breast cancer
- •- Evidence of metastatic disease
- •- History of invasive breast cancer
- •- Previous treatment of the ipsilateral axilla with surgery or radiotherapy,
- •except surgery for hidradenitis suppurativa or for other superficially located
- •skin lesions, such as naevi
- •- Pregnant or nursing
- •- Other prior malignancies within the past 5 years, except successfully treated
- •malignancies that occurred more than five years before randomization, and
- •except successfully treated basal cell and squamous cell skin cancer, carcinoma
- •in situ of the cervix or carcinoma in situ of the ipsilateral or contralateral
- •- Unable or unwilling to give informed consent
研究者
相似试验
招募中
不适用
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up (BOOG 2013-08).breast neoplasmssentinel lymph node biopsybreast conserving therapy.breast cancerNL-OMON28389KWF, CZ, ZonMw1,644
招募中
不适用
BOOG 2013-08: Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up.breast cancerNL-OMON22593KWFCZZonMw1,644
进行中（未招募）
1 期
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerEUCTR2012-002039-28-ESSandoz GmbH308
已完成
3 期
A study to evaluate the Efficacy and Safety of LA-EP2006 and Neulasta® in patients with breast cancer.CTRI/2012/10/003065Sandoz GmbH302
已完成
不适用
Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer.early or locally advanced breast cancerWomen at increased risk for carrying a faulty gene for breast and/or ovarian cancerCancer - BreastHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12610000502033Prince of Wales Hospital120